281 related articles for article (PubMed ID: 35382748)
41. Is Helicobacter pylori the cause of dyspepsia?
Bernersen B; Johnsen R; Bostad L; Straume B; Sommer AI; Burhol PG
BMJ; 1992 May; 304(6837):1276-9. PubMed ID: 1606428
[TBL] [Abstract][Full Text] [Related]
42. CagA status in dyspeptic patients with and without peptic ulcer disease in Turkey: association with histopathologic findings.
Demirtürk L; Ozel AM; Yazgan Y; Solmazgül E; Yildirim S; Gültepe M; Gürbüz AK
Helicobacter; 2001 Jun; 6(2):163-8. PubMed ID: 11422473
[TBL] [Abstract][Full Text] [Related]
43. Endoscopic findings and prevalence of Helicobacter pylori in Kenyan patients with dyspepsia.
Ogutu EO; Kang'ethe SK; Nyabola L; Nyong'o A
East Afr Med J; 1998 Feb; 75(2):85-9. PubMed ID: 9640829
[TBL] [Abstract][Full Text] [Related]
44. Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998.
Xia HH; Phung N; Altiparmak E; Berry A; Matheson M; Talley NJ
Dig Dis Sci; 2001 Dec; 46(12):2716-23. PubMed ID: 11768265
[TBL] [Abstract][Full Text] [Related]
45. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease.
Xia HH; Phung N; Kalantar JS; Talley NJ
Med J Aust; 2000 Nov; 173(10):515-9. PubMed ID: 11194733
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of H. Pylori in Perforated Peptic Ulcer Disease at Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Tadesse M; Musie E; Teklewold B; Hailu E
Ethiop J Health Sci; 2021 Sep; 31(5):969-974. PubMed ID: 35221613
[TBL] [Abstract][Full Text] [Related]
47. The role of autonomic neuropathy as a risk factor of Helicobacter pylori infection in dyspeptic patients with type 2 diabetes mellitus.
Gentile S; Turco S; Oliviero B; Torella R
Diabetes Res Clin Pract; 1998 Oct; 42(1):41-8. PubMed ID: 9884032
[TBL] [Abstract][Full Text] [Related]
48. Magnitude of Helicobacter pylori and associated risk factors among symptomatic patients attending at Jasmin internal medicine and pediatrics specialized private clinic in Addis Ababa city, Ethiopia.
Shiferaw G; Abera D
BMC Infect Dis; 2019 Feb; 19(1):118. PubMed ID: 30727997
[TBL] [Abstract][Full Text] [Related]
49. Endoscopic findings and the prevalence of Helicobacter pylori in chronic renal failure patients with dyspepsia.
Karari EM; Lule GN; McLigeyo SO; Amayo EO
East Afr Med J; 2000 Aug; 77(8):406-9. PubMed ID: 12862061
[TBL] [Abstract][Full Text] [Related]
50. Prevalence and risk factors of H. pylori from dyspeptic patients in northwest Ethiopia: a hospital based cross-sectional study.
Abebaw W; Kibret M; Abera B
Asian Pac J Cancer Prev; 2014; 15(11):4459-63. PubMed ID: 24969869
[TBL] [Abstract][Full Text] [Related]
51. Helicobacter pylori infection, anti-cagA antibodies and peptic ulcer: a case-control study in Italy.
Palli D; Menegatti M; Masala G; Ricci C; Saieva C; Holton J; Gatta L; Miglioli M; Vaira D
Aliment Pharmacol Ther; 2002 May; 16(5):1015-20. PubMed ID: 11966512
[TBL] [Abstract][Full Text] [Related]
52. Incidence of Helicobacter pylori infection in Ghanaian patients with dyspeptic symptoms referred for upper gastrointestinal endoscopy.
Baako BN; Darko R
West Afr J Med; 1996; 15(4):223-7. PubMed ID: 9020601
[TBL] [Abstract][Full Text] [Related]
53. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.
Hawkey CJ; Tulassay Z; Szczepanski L; van Rensburg CJ; Filipowicz-Sosnowska A; Lanas A; Wason CM; Peacock RA; Gillon KR
Lancet; 1998 Sep; 352(9133):1016-21. PubMed ID: 9759744
[TBL] [Abstract][Full Text] [Related]
54. Helicobacter pylori infection in dyspeptic cirrhotic patients.
Zullo A; Rinaldi V; Meddi P; Folino S; Lauria V; Diana F; Winn S; Attili AF
Hepatogastroenterology; 1999; 46(25):395-400. PubMed ID: 10228829
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of Helicobacter pylori in dyspeptic patients at a tertiary hospital in a low resource setting.
Oling M; Odongo J; Kituuka O; Galukande M
BMC Res Notes; 2015 Jun; 8():256. PubMed ID: 26100113
[TBL] [Abstract][Full Text] [Related]
56. Silent peptic ulcer disease: frequency, factors leading to "silence," and implications regarding the pathogenesis of visceral symptoms.
Lu CL; Chang SS; Wang SS; Chang FY; Lee SD
Gastrointest Endosc; 2004 Jul; 60(1):34-8. PubMed ID: 15229422
[TBL] [Abstract][Full Text] [Related]
57. [Dyspepsia and Helicobacter pylori infection in employees of a large industry. Results of a prospective BASF Helicobacter pylori prevention campaign].
Schilling D; Messerer P; Ott MG; Schauwecker P; Zober A; Riemann JF
Med Klin (Munich); 2002 Jan; 97(1):6-11. PubMed ID: 11831064
[TBL] [Abstract][Full Text] [Related]
58. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study.
Nagata N; Niikura R; Sekine K; Sakurai T; Shimbo T; Kishida Y; Tanaka S; Aoki T; Okubo H; Watanabe K; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
J Gastroenterol Hepatol; 2015 Feb; 30(2):292-8. PubMed ID: 25339607
[TBL] [Abstract][Full Text] [Related]
59. Epidemiology of Helicobacter pylori infection in dyspeptic Ghanaian patients.
Archampong TN; Asmah RH; Wiredu EK; Gyasi RK; Nkrumah KN; Rajakumar K
Pan Afr Med J; 2015; 20():178. PubMed ID: 26430475
[TBL] [Abstract][Full Text] [Related]
60. High prevalence of duodenal ulcer and gastric cancer in dyspeptic patients in Korea.
Malaty HM; Kim JG; El-Zimaity HM; Graham DY
Scand J Gastroenterol; 1997 Aug; 32(8):751-4. PubMed ID: 9282964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
